Clinical trial
A Study to Monitor Intragastric pH in Patients Taking Rabeprazole vs. Patients…
NCT00378287 · Janssen-Ortho Inc., Canada, Industry · Completed
Key facts
| NCT number | NCT00378287 |
|---|---|
| Title | A Study to Monitor Intragastric pH in Patients Taking Rabeprazole vs. Patients Taking Pantoprazole |
| Official title | A Randomized, Controlled, Double-blind, Cross-over Study of the Effect of Oral Rabeprazole 20mg and Intravenous Pantoprazole 40mg on Intragastric pH in Patients |
| Lead sponsor | Janssen-Ortho Inc., Canada, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | GERD |
| Intervention type | Drug |
| Interventions | rabeprazole sodium |
| Enrollment | 37 |
| Start date | Oct 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Sep 19, 2006 |
| Last update posted | Dec 10, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: